期刊文献+

体重对个体化控制性超排卵下ART结局的影响 被引量:1

Impact of weight on ART outcome by individualized controlled ovarian stimulation protocol
下载PDF
导出
摘要 目的探讨患者体重对个体化控制性超排卵(COS)策略下辅助生殖技术(ART)治疗结局的影响。方法选择245个黄体中期长方案的体外受精(IVF)或卵胞浆内单精子注射(ICSI)周期,按世界卫生组织(WHO)亚洲人体重指数(BMI)标准分成正常体重组176例(BMI18.5~22.9kg/m2)及高BMI组69例(BMI≥23kg/m2),回顾性分析比较两组ART结局。结果高BMI组促性腺激素释放激素激动剂(GnRHa)用量(1.6±0.2)mg、促性腺激素(Gn)使用天数(12.4±3.6)d显著大于正常体重组[分别为(1.5±0.3)mg、(11.5±2.4)d],高BMI组HCG日平均雌二醇(E2)值(1883.6±1065.3)pg/mL、获卵率(69.8%)显著低于正常体重组[分别为(2525.7±1234.5)pg/mL、74.8%],两者比较,差异均有显著性(P<0.05);HCG日高BMI组子宫内膜厚度显著低于正常体重组(P<0.05),但其增厚内膜与菲薄内膜构成比在两组间差异无显著性(P>0.05);中重度卵巢过度刺激综合征(OHSS)发生率、获卵数、成熟卵子数/率、受精数/率、优质胚胎数/率、移植胚胎数、胚胎植入率、临床妊娠率及早期流产率,两组比较差异均无显著性(P>0.05)。结论在个体化COS策略下,高BMI可降低卵巢对Gn刺激的反应性,但不会影响ART治疗后早期妊娠结局。 【Objective】To assess the impact of weight on the outcome of assisted reproductive technology (ART) by individualized ovarian stimulation (COS) protocol. 【Methods】According to World Health Organization(WHO) body mass index (BMI) criteria for Asians, 245 in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) cycles using mid-luteal long gonadotropin releasing hormone agonist (GnRHa) protocols were divided into two groups by a cutoff of 24 kg/m2; normal weight (BMI 18.5-22.9 kg/m2; n =176 cycles) and overweight (BMI ≥23 kg/m2; n = 69 cycles).【Results】Dose of GnRHa and days of ovarian stimulation were significantly higher in the overweight group (P 0.05); the mean serum estradiol (E2) level on hCG day and the rate of retrieval oocytes were significantly lower in the overweight group (P 0.05). Endometrial thickness on hCG day was significantly lower in the overweight group (P 0.05), but for the proportion of thick and thin endometrium, there was no significant difference in the two groups (P 0.05); the incidence of moderate-severe ovarian hyperstimulation syndrome (OHSS), the number of retrieval oocytes, the number/rate of mature oocytes, the number/rate of fertilization, the mean number/rate of highquality embryos, the mean number of embryos transferred, implantation rate, clinical pregnancy rate and early pregnancy loss rate were comparable between the two groups(P0.05).【Conclusion】Overweight may cause a lower stimulation response, but cannot affect early pregnancy outcome after ART treatment by individualized COS protocal.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2010年第5期753-755,759,共4页 China Journal of Modern Medicine
基金 国家自然科学基金(No:30872769) 南方医院新技术新项目基金(No:2006002)
关键词 体重指数 辅助生殖技术 妊娠结局 body mass index assisted reproductive technology pregnancy outcome
  • 相关文献

参考文献1

二级参考文献14

  • 1杨小玉,张云山.IVF-ET妇女的心理反应及其影响和干预[J].国外医学(计划生育分册),2005,24(4):168-171. 被引量:24
  • 2Out HJ. Recombinant follicle-stimulating hormone: gold standard or not? [ J ]. Reprod Biomed Online, 2005, 11 (5): 536-9.
  • 3Voortman G, van de Post J, Schoemaker RC, van Gerven MA. Bioequivalence of subcutaneous injections of recombinant human follicle stimulating hormone (Puregon) by Pen-injector and syringe[J]. Hum Reprod, 1999, 14(7): 1498-702.
  • 4Craenmehr E, Bontje PM, Hoomans E, et al. Follitropin-beta administered by pen device has superior local tolerance compared with follitropin-alpha administered by conventional syringe [J]. Reprod Biomed Online, 2001, 3 (3): 185-9.
  • 5Kettel LM, Scholl G, Bonaventura L, et al. Evaluation of a pen device for self-administration of recombinant human FSH in clomiphene citrate-resistant anovulatory women undergoing ovulation induction [J ]. Reprod Biomed Online, 2004, 9 (4): 373-80.
  • 6Out HJ, Mannaerts BMJL, Driessen SGAJ, et al. Recombinant follicle-stimulating hormone (follitropin beta, Puregon) yields higher pregnancy rates in in vitro fertilization than urinary gonadotrophins [ J ]. Ferti Steril, 1997, 68 ( 1 ): 138-42.
  • 7Harlin J, Csemiczky G, Wramsby H, et al. Recombinant follicle stimulating hormone in in vitro fertilization treatment: clinical experience with follitropin alfa and follitropin beta [J]. Hum Reprod, 2000, 15 (2) :239-44.
  • 8Porter R, Kissel C, Saunders H, et al. Patient and nurse evaluation of recombinant human follicle-stimulating hormone administration methods: comparison of two follitropin injection pens[J]. Curr Med Res Opin, 2008, 24(3): 727-35.
  • 9Muasher S J, Abdallah RT, Hubayter ZR. Optimal stimulation protocols for in vitro fertilization [J]. Fertil Steril, 2006, 86(2): 267-73.
  • 10Platteau P, Laurent E, Albano C, et al. An open, randomized single-centre study to compare .the efficacy and convenience of follitropin beta administered by a pen device with follitropin alpha administered by a conventional syringe in women undergoing ovarian stimulation for IVF/ICSI [J]. Hum Reprod, 2003, 18 (6): 1200-4.

共引文献19

同被引文献15

  • 1Scheffer GJ,Broekmans FJ,Dorland M,et al.Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility[J].Fertil Steril,1999,72(5):845-851.
  • 2Hendriks DJ,Mol BW,Bancsi LF,et al.Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization:a meta-analysis and comparison with basal follicle-stimulating hormone level[J].Fertil Steril,2005,83(2):291-301.
  • 3Serour G,Mansour R,Serour A,et al.Analysis of2386consecutive cycles of in vitro fertilization or intracytoplasmic sperm injection using autologous oocytes in women aged40years and above[J].Fertil Steril,2009,5.[Epub ahead of print].
  • 4Maseelall PB,Hernandez-Rey AE,Oh C,et al.Antral follicle count is a significant predictor of livebirth in vitro fertilization cycles[J].Fertil Steril,2009,91(4):1595-1597.
  • 5Kwee J,Elting ME,Schats R,et al.Ovarian volume and antral follicle count for the prediction of low and hyper responders with in vitro fertilization[J].Reprod Biol Endocrinol,2007,15(1):5-9.
  • 6Chang MY,Chiang CH,Hsieh TT,et al.Use of the antral follicle count to predict the outcome of assisted reproductive technologies[J].Fertil Steril,1998,69(3):505-510.
  • 7Broekmans FJ,Kwee J,Hendriks DJ,et al.A systematic review of tests predicting ovarian reserve and IVF outcome[J].Hum Reprod Update,2006,12(6):685-718.
  • 8Bancsi LF,Broekmans FJ,Eijkemans MJ,et al.Predictors of poor ovarian response in in vitro fertilization:a prospective study comparing basal markers of ovarian reserve[J].Fertil Steril,2002,77(2):328-336.
  • 9Hendriks DJ,Kwee J,Mol BW,et al.Ultrasonography as a tool for the prediction of outcome in IVF patients:a comparative meta-analysis of ovarian volume and antral follicle count[J].Fertil Steril,2007,87(4):764-775.
  • 10Avril C.Antral follicle count and oocyte quality[J].J Gynecol Obstet Biol Reprod(Paris),2006,35(5Pt2):2S42-2S43.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部